Table 1 Individuals’ basic characteristics categorized based on ACAG
Characteristic | Total cohort (n = 2160) | Tertile of the ACAG | P | ||
|---|---|---|---|---|---|
< 17.50(712) | 17.50–21.75(706) | > = 21.75(742) | |||
Age, years | 72.60 (19.77–97.47) | 72.80 (22.84–97.47) | 73.25 (19.77–96.75) | 71.53 (21.65–97.42) | 0.011 |
Female, n (%) | 891 (41.25%) | 277 (38.90%) | 302 (42.78%) | 312 (42.05%) | 0.288 |
Ethnicity, n %) | < 0.001 | ||||
White | 1413 (65.42%) | 468 (65.73%) | 484 (68.56%) | 461 (62.13%) | |
Black | 205 (9.49%) | 51 (7.16%) | 61 (8.64%) | 93 (12.53%) | |
Asian | 46 (2.13%) | 9 (1.26%) | 14 (1.98%) | 23 (3.10%) | |
Unknown | 496 (22.96%) | 184 (25.84%) | 147 (20.82%) | 165 (22.24%) | |
AF, n(%) | 821 (38.01%) | 251 (35.25%) | 287 (40.65%) | 283 (38.14%) | 0.111 |
Hypertension, n(%) | 753 (34.86%) | 300 (42.13%) | 258 (36.54%) | 195 (26.28%) | < 0.001 |
Hyperlipidemia, n(%) | 1102 (51.02%) | 397 (55.76%) | 356 (50.42%) | 349 (47.04%) | 0.004 |
CCI | 7.00 (1.00–20.00) | 7.00 (1.00–18.00) | 8.00 (1.00–20.00) | 8.00 (1.00–17.00) | < 0.001 |
MV, n(%) | 919 (42.55%) | 276 (38.76%) | 270 (38.24%) | 373 (50.27%) | < 0.001 |
Vasoactive drugs, n(%) | 1129 (52.27%) | 312 (43.82%) | 359 (50.85%) | 458 (61.73%) | < 0.001 |
β-blockers, n(%) | 1136 (52.59%) | 427 (59.97%) | 362 (51.27%) | 347 (46.77%) | < 0.001 |
CABG, n(%) | 294 (13.61%) | 173 (24.30%) | 82 (11.61%) | 39 (5.26%) | < 0.001 |
PCI, n(%) | 357 (16.53%) | 141 (19.80%) | 126 (17.85%) | 90 (12.13%) | < 0.001 |
Heart rate, bpm | 88.00 (34.00–179.00) | 82.00 (40.00–157.00) | 89.00 (34.00–179.00) | 93.00 (41.00–179.00) | < 0.001 |
SBP, mmHg | 119.00 (46.00–229.00) | 121.00 (65.00–204.00) | 119.00 (47.00–229.00) | 118.00 (46.00–220.00) | 0.023 |
DBP, mmHg | 67.00 (11.00–190.00) | 68.00 (18.00–171.00) | 66.00 (11.00–176.00) | 66.00 (11.00–190.00) | 0.290 |
Weight, Kg | 78.70 (33.60–231.50) | 78.12 (35.70–201.00) | 79.00 (35.80–231.50) | 78.10 (33.60–181.70) | 0.756 |
SPO2, % | 97.00 (14.00–100.00) | 98.00 (14.00–100.00) | 97.00 (62.00–100.00) | 97.50 (59.00–100.00) | 0.041 |
Albumin, g/dl | 3.40 (0.80–5.40) | 3.50 (1.20–5.00) | 3.30 (1.00–5.20) | 3.20 (0.80–5.40) | < 0.001 |
AG, mmol/L | 17.00 (5.00–56.00) | 13.00 (5.00–18.00) | 17.00 (11.00–22.00) | 22.00 (15.00–56.00) | < 0.001 |
CK-MB, U/L | 11.00 (1.00–673.00) | 12.00 (1.00–594.00) | 10.00 (1.00–575.00) | 12.00 (1.00–673.00) | 0.196 |
Troponin-T, ng/ml | 0.44 (0.01–51.84) | 0.43 (0.01–24.98) | 0.44 (0.01–41.30) | 0.47 (0.01–51.84) | 0.350 |
Outcome, n(%) | |||||
Stroke | 36 (1.67%) | 10 (1.40%) | 12 (1.70%) | 14 (1.89%) | 0.770 |
Bleeding | 298 (13.80%) | 77 (10.81%) | 93 (13.17%) | 128 (17.25%) | 0.002 |
30-day mortality | 430 (19.91%) | 81 (11.38%) | 125 (17.71%) | 224 (30.19%) | < 0.001 |